Skip navigation

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Results 1 - 10 of 15 for Speech therapy
  1. Ataxia-telangiectasia 
    ... improve some symptoms. These treatments include physical and speech therapy and improving deficits in the immune system and ...
    https://medlineplus.gov/genetics/condition/ataxia-telangiectasia - Genetics
  2. CHD2 myoclonic encephalopathy 
    ... refractory because they usually do not respond to therapy with anti-epileptic medications.Other signs and symptoms of CHD2 myoclonic encephalopathy include intellectual disability that ranges from mild to severe and delayed development of speech. Rarely, individuals can have a loss of acquired ...
    https://medlineplus.gov/.../condition/chd2-myoclonic-encephalopathy - Genetics
  3. Chromosome 22 
    ... the Philadelphia chromosome provides a target for molecular therapies. More About This Health Condition A rearrangement (translocation) ... effects. Intellectual disability, delayed development, delayed or absent speech, distinctive facial features, and behavioral problems are common ...
    https://medlineplus.gov/genetics/chromosome/22 - Genetics
  4. Pelizaeus-Merzbacher disease 
    ... A. Pelizaeus-Merzbacher disease: cellular pathogenesis and pharmacologic therapy. Pediatr Int. 2014 Oct;56(5):659-66. ...
    https://medlineplus.gov/.../condition/pelizaeus-merzbacher-disease - Genetics
  5. STXBP1 encephalopathy 
    ... as refractory because they do not respond to therapy with anti-epileptic medications.Other neurological problems that ... J. STXBP1 encephalopathies: Clinical spectrum, disease mechanisms, and therapeutic strategies. J Neurochem. 2021 Apr;157(2):165- ...
    https://medlineplus.gov/genetics/condition/stxbp1-encephalopathy - Genetics
  6. CACNA1C gene 
    ... Pathophysiology of Calcium Mediated Ventricular Arrhythmias and Novel Therapeutic Options with Focus on Gene Therapy. Int J Mol Sci. 2019 Oct 24;20( ...
    https://medlineplus.gov/genetics/gene/cacna1c - Genetics
  7. Usher syndrome 
    ... deafness and retinitis pigmentosa): pathogenesis, molecular diagnosis and therapeutic approaches. Curr Opin Neurol. 2012 Feb;25(1): ...
    https://medlineplus.gov/genetics/condition/usher-syndrome - Genetics
  8. Aspartylglucosaminuria 
    ... M, Lund TC. Aspartylglucosaminuria: Clinical Presentation and Potential Therapies. J Child Neurol. 2021 Apr;36(5):403- ...
    https://medlineplus.gov/genetics/condition/aspartylglucosaminuria - Genetics
  9. Huntington's disease 
    ... s disease: from pathology and genetics to potential therapies. Biochem J. 2008 Jun 1;412(2):191- ...
    https://medlineplus.gov/genetics/condition/huntingtons-disease - Genetics
  10. Niemann-Pick disease 
    ... Type A Niemann-Pick disease: possible endpoints for therapeutic trials. Neurology. 2006 Jan 24;66(2):228- ...
    https://medlineplus.gov/genetics/condition/niemann-pick-disease - Genetics
previous · 1 · 2 · next